Literature DB >> 34841964

A Bayesian approach for estimating the partial potential impact fraction with exposure measurement error under a main study/internal validation design.

Xinyuan Chen1, Joseph Chang2, Donna Spiegelman2,3,4, Fan Li3,4.   

Abstract

The partial potential impact fraction describes the proportion of disease cases that can be prevented if the distribution of modifiable continuous exposures is shifted in a population, while other risk factors are not modified. It is a useful quantity for evaluating the burden of disease in epidemiologic and public health studies. When exposures are measured with error, the partial potential impact fraction estimates may be biased, which necessitates methods to correct for the exposure measurement error. Motivated by the health professionals follow-up study, we develop a Bayesian approach to adjust for exposure measurement error when estimating the partial potential impact fraction under the main study/internal validation study design. We adopt the reclassification approach that leverages the strength of the main study/internal validation study design and clarifies transportability assumptions for valid inference. We assess the finite-sample performance of both the point and credible interval estimators via extensive simulations and apply the proposed approach in the health professionals follow-up study to estimate the partial potential impact fraction for colorectal cancer incidence under interventions exploring shifting the distributions of red meat, alcohol, and/or folate intake.

Entities:  

Keywords:  Health professionals follow-up study; internal validation study; measurement error; potential impact fraction; pólya-gamma latent variables; transportability

Mesh:

Year:  2021        PMID: 34841964     DOI: 10.1177/09622802211060514

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  1 in total

1.  Individual differences in the effects of the ACTION-PAC intervention: an application of personalized medicine in the prevention and treatment of obesity.

Authors:  Alena Kuhlemeier; Thomas Jaki; Elizabeth Y Jimenez; Alberta S Kong; Hope Gill; Chi Chang; Ken Resnicow; Dawn K Wilson; M Lee Van Horn
Journal:  J Behav Med       Date:  2022-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.